Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 53, Issue 3, Pages 285-305Publisher
ELSEVIER
DOI: 10.1016/S0169-409X(01)00233-2
Keywords
Liposomes; hyperthermia; doxorubicin; FaDu tumors; lysolipid
Categories
Funding
- NCI NIH HHS [CA 40355, CA 87630, CA 42745] Funding Source: Medline
- NIGMS NIH HHS [GM 40162] Funding Source: Medline
Ask authors/readers for more resources
Our laboratories have been working together in close collaboration for over 10 years concerning the design and performance of lipid-based drug delivery systems. Over the past 3 years we have conceived of, developed, and tested pre-clinically, a new liposome-based temperature-sensitive drug delivery system for the treatment of solid tumors. This work is reported in a series of four publications: 'J. Liposome Res. 9 (1999) 491; Cancer Res. Adv. Brief 60(5) (2000) 1197; Cancer Res. 6(9) (2000) 748; and Cancer Res. 60 (2000) 6950'. Following a brief introduction concerning the motivations behind the work, this article will review these studies, including some of our earlier work that led to these ideas, and will present the rational design of the new liposome formulation from a materials engineering perspective. (C) 2001 Published by Elsevier Science B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available